98%
921
2 minutes
20
Objectives: We developed and evaluated the psychometric properties of the Sleep Acceptance Scale (SAS), a tool designed to measure sleep acceptance via cognitive and emotional responses to sleep problems.
Method: We designed a six-item scale, rated on a 7-point Likert scale, to capture the nuances of sleep acceptance. Data were collected from 1,350 participants, both with and without sleep problems. We employed an Exploratory Graph Analysis (EGA) and a Confirmatory Factor Analysis (CFA) to assess internal consistency, convergent validity, and measurement invariance over time and between groups.
Results: The EGA revealed a unidimensional structure for the SAS, which the CFA also confirmed. However, the root mean square error of approximation was marginally above the ideal threshold. The scale demonstrated high internal consistency ( = 0.91) and strong correlations with measures of insomnia severity, anxiety, depression, and willingness, supporting its convergent validity. Although the SAS maintained temporal stability over 14 days, it lacked configural invariance between good and bad sleepers, suggesting potential differences in how sleep acceptance manifested across these groups.
Conclusions: The SAS effectively measures sleep acceptance, capturing important cognitive and emotional dimensions. It can be used to monitor progress in acceptance and commitment therapy and mindfulness-based interventions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/15402002.2025.2555864 | DOI Listing |
JMIR Form Res
September 2025
Department of Psychological Science, School of Social Ecology, University of California, Irvine, 4201 Social and Behavioral Sciences Gateway, Irvine, CA, 92697, United States, 1 203-887-8857.
Background: Rates of loneliness have risen sharply since the onset of the COVID-19 pandemic, largely due to disruptions in social relationships and daily routines, with college students experiencing some of the greatest increases. While prevention programs targeting loneliness have been developed, their success has been limited. One promising approach may lie in enhancing the quality of existing relationships rather than simply increasing social interactions during periods of acute loneliness.
View Article and Find Full Text PDFJ Epidemiol
September 2025
Faculty of Sport Sciences, Waseda University.
Background: Brief measures of 24-hour movement behaviors are needed to easily evaluate their durations. The present study investigated the criterion validity and test-retest reliability of a brief self-report instrument to assess 24-hour movement behaviors.
Methods: A paper-based self-administered questionnaire was used to assess sleep, sedentary behavior (SB), light-intensity physical activity (LPA), and moderate-to-vigorous physical activity (MVPA) with four items in 35 healthy adults.
Clin Ther
September 2025
Avadel Pharmaceuticals, Chesterfield, Missouri.
Purpose: Narcolepsy is a chronic neurologic disorder characterized by excessive daytime sleepiness (EDS) and can occur with or without cataplexy. Once-nightly sodium oxybate (ON-SXB) is approved for the treatment of cataplexy or EDS in patients 7 years of age or older with narcolepsy. ON-SXB contains both immediate-release and pH-dependent, controlled-release granules designed to be reconstituted in water and administered orally once at bedtime.
View Article and Find Full Text PDFPhysiotherapy
June 2025
PenCRU (Peninsula Childhood Disability Research Unit), Department of Health & Community Sciences, University of Exeter Medical School, University of Exeter, St Luke's Campus EX1 2LU, UK. Electronic address:
Objectives: Children and young people with complex neurodisability (CYPCN) are at high risk of respiratory illness, frequent hospital admissions and premature death. This study aimed to test the acceptability and feasibility of Breathe-Easy, a novel night-time postural intervention to improve respiratory health in CYPCN.
Design: Case series design incorporating a pre-post interventional study and qualitative study.
Z Rheumatol
September 2025
Clinic of Internal Medicine III, Department of Oncology, Hematology, Cell and Immunotherapies, Clinical Immunology and Rheumatology, University Hospital Bonn, Venusberg Campus 1, 53127, Bonn, Germany.
Background: Interstitial lung diseases (ILD) represent an interdisciplinary clinical challenge and are not uncommonly associated with rheumatological diseases. Interstitial lung disease multidisciplinary meetings (ILD-MDM) provide a structured platform for interdisciplinary case discussions and decision making. Despite their great importance in patient care, data on the prevalence, structure and function of ILD-MDM in Germany are lacking.
View Article and Find Full Text PDF